FeesSafety
Pluang+

New blood test screening method may speed up Alzheimer's trial participant selection

Market News
17 Nov 2026, 13:00 WIB
GlobeNewsWire
View Source
Bullish
New blood test screening method may speed up Alzheimer's trial participant selection

Cognition Therapeutics and the Alzheimer’s Clinical Trials Consortium presented a new screening strategy at the CTAD conference that uses a blood test measuring plasma p-tau217 to efficiently screen participants for an Alzheimer's clinical trial. This method reduces reliance on costly and time-consuming PET scans by excluding ineligible participants earlier, easing the burden on trial sites and participants. The approach was tested in Cognition’s Phase 2 START study, which is evaluating the oral drug zervimesine for mild cognitive impairment and early Alzheimer’s disease. Top-line results are expected after 18 months of treatment completion, potentially improving future Alzheimer's trial designs by making screening faster and less invasive.

Cognition Therapeutics' new screening strategy for Alzheimer's trials is the story's focus, with Pluang's Health-sector snapshot providing context. As of Nov 17, 2026 17:11 WIB, out of 150 priced Health-sector US stocks tradable on Pluang, 48 rose and 85 fell. Notable movers include NTRA at USD 297.00 with a 1-day change of +2.95% and 100% buy order activity, COGT at USD 28.20 with +2.77% but 100% sell order activity, and SANA at USD 1.93 with +2.66% and 100% buy order activity.

More News

Microsoft expands use of Haivision tech for live production of 600+ global events annually

Microsoft expands use of Haivision tech for live production of 600+ global events annually

Microsoft has expanded its partnership with Haivision by adopting the Makito ONE video transport platform, Makito X4 video encoders and decoders, Haivision Pro mobile transmitters, and Haivision Hub 360 for live production of over 600 global events e...

Market News
Bullish
1 hour ago
Piper Sandler upgrades Medtronic on growth from acquisitions and new treatments.

Piper Sandler upgrades Medtronic on growth from acquisitions and new treatments.

Piper Sandler upgraded Medtronic to Overweight with a $120 price target, citing strategic growth through acquisitions and product launches in vascular, heart rhythm, and robotic surgery. Medtronic's recent acquisition of Contego Medical expands its c...

Analyst Insights
Bullish
2 hours ago
NVIDIA forms new committee to oversee national security and export control compliance.

NVIDIA forms new committee to oversee national security and export control compliance.

NVIDIA's Board of Directors has established the National Security and Export Control Oversight Committee to manage the company's national security policies and export control compliance. Chaired by Suzanne Nora Johnson, the committee will oversee NVI...

Market News
Neutral
2 hours ago
Malaysia's e-commerce market to nearly double to $25.65B by 2032, driven by mobile shopping and digital payments.

Malaysia's e-commerce market to nearly double to $25.65B by 2032, driven by mobile shopping and digital payments.

Malaysia's e-commerce market is projected to grow from $13.85 billion in 2027 to $25.65 billion by 2032, with a CAGR of 13.12%. Growth is fueled by increased smartphone use, digital wallet adoption, expanding logistics, and social commerce. B2C remai...

Market News
Bullish
2 hours ago
Burning Rock schedules 2026 AGM on Dec 22 to approve auditor and re-elect directors

Burning Rock schedules 2026 AGM on Dec 22 to approve auditor and re-elect directors

Burning Rock Biotech Limited announced its 2026 Annual General Meeting will be held on December 22, 2026, at its Shanghai office. The meeting will cover ratifying Ernst & Young Hua Ming LLP as auditor for 2026, re-electing directors Zhihong Zhang and...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App